Showing results (161-170 of 222) with videos related to

Sort By:
Pageof 23
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 19, 2005
Heterotopic vs. orthotopic liver transplantation for chronic liver disease: a case-control comparison of short-term and long-term outcomesSjoerd de Rave, Bettina E Hansen, Theo H N Groenland, et al.
Clinical Nutrition ESPEN|March 30, 2020
Identification and prognostic impact of malnutrition in a population screened for liver transplantationRosalie C Oey, Pim Aarts, Nicole S Erler, et al.
Current Problems in Diagnostic Radiology|July 13, 2024
Evaluation of Hepatocellular Carcinoma Surveillance with Contrast-enhanced MRI in a High-Risk Western European CohortFederico I F Fiduzi, François E J A Willemssen, Céline van de Braak, et al.
Journal of Medical Virology|January 20, 2009
An improved approach to identify epidemiological and phylogenetic transmission pairs of source and contact tracing of hepatitis BIrene K Veldhuijzen, Ted H M Mes, Maria C Mostert, et al.
The Journal of Infectious Diseases|May 22, 2022
Levels of Antibodies to Hepatitis B Core Antigen Are Associated With Liver Inflammation and Response to Peginterferon in Patients With Chronic Hepatitis BSylvia M Brakenhoff, Robert J de Knegt, Jeffrey Oliveira, et al.
The American Journal of Gastroenterology|October 13, 2006
Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudineHajo J Flink, Bettina E Hansen, E Jenny Heathcote, et al.
Antiviral Therapy|February 5, 2008
Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis BMartijn J ter Borg, Bettina E Hansen, Eva Herrmann, et al.
Gastroenterology|November 7, 2007
Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis BRobert G Gish, Anna S Lok, Ting-Tsung Chang, et al.
Journal of Viral Hepatitis|November 2, 2020
Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infectionMidas B Mulder, Robert A de Man, Nassim Kamar, et al.
Journal of Viral Hepatitis|September 1, 2022
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis BKin Seng Liem, Heng Chi, Scott Fung, et al.
Pageof 23